LYC Healthcare Berhad Toekomstige groei

Future criteriumcontroles 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for LYC Healthcare Berhad.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

IT winstgroei	13.8%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Shareholders May Be More Conservative With LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation For Now

Sep 20

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 14

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jul 04

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Mar 26

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Feb 01

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Sep 15

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

Sep 10

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

May 11

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Nov 29

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jun 13

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Mar 01

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat LYC Healthcare Berhad onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

KLSE:LYC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (MYR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2024	143	-20	4	7	N/A
3/31/2024	130	-19	3	9	N/A
12/31/2023	121	-17	-11	-4	N/A
9/30/2023	108	-17	-4	2	N/A
6/30/2023	98	-17	-7	0	N/A
3/31/2023	92	-19	2	5	N/A
12/31/2022	86	-12	21	19	N/A
9/30/2022	84	-12	3	5	N/A
6/30/2022	74	-11	-1	2	N/A
3/31/2022	65	-9	-3	0	N/A
12/31/2021	58	-11	-10	-3	N/A
9/30/2021	44	-12	-4	-1	N/A
6/30/2021	35	-12	-2	1	N/A
3/31/2021	26	-12	-6	-2	N/A
12/31/2020	16	-14	-8	3	N/A
9/30/2020	13	-12	-10	0	N/A
6/30/2020	12	-11	-12	-1	N/A
3/31/2020	12	-10	-12	-1	N/A
12/31/2019	12	-8	-11	-7	N/A
9/30/2019	10	-8	-8	-4	N/A
6/30/2019	6	-8	-7	-4	N/A
3/31/2019	8	-8	-7	-4	N/A
12/31/2018	6	-7	-9	-1	N/A
9/30/2018	6	-6	-11	-3	N/A
6/30/2018	7	-4	-10	-3	N/A
3/31/2018	6	-3	N/A	-2	N/A
3/31/2017	33	-2	N/A	-2	N/A
9/30/2016	35	-1	N/A	-4	N/A
6/30/2016	39	-1	N/A	-1	N/A
3/31/2016	42	-2	N/A	-1	N/A
12/31/2015	40	-2	N/A	-3	N/A
9/30/2015	40	-2	N/A	0	N/A
6/30/2015	43	0	N/A	-3	N/A
3/31/2015	44	0	N/A	-1	N/A
12/31/2014	43	-1	N/A	-1	N/A
9/30/2014	41	-2	N/A	-3	N/A
6/30/2014	33	-3	N/A	-4	N/A
3/31/2014	32	-3	N/A	-5	N/A
12/31/2013	33	-3	N/A	-2	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if LYC's forecast earnings growth is above the savings rate (3.6%).

Winst versus markt: Insufficient data to determine if LYC's earnings are forecast to grow faster than the MY market

Hoge groeiwinsten: Insufficient data to determine if LYC's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: Insufficient data to determine if LYC's revenue is forecast to grow faster than the MY market.

Hoge groei-inkomsten: Insufficient data to determine if LYC's revenue is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if LYC's Return on Equity is forecast to be high in 3 years time

LYC Healthcare Berhad Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

LYC Healthcare Berhad Appoints Kong Sin Seng as Independent and Non Executive Chairman of Audit Committee

Wong Chew Weng agreed to acquire an additional 55% stake in Elite Dental Team Sdn Bhd from LYC Healthcare Berhad (KLSE:LYC) for MYR 6.5 million.

LYC Healthcare Berhad Approves Audit Committee Be Changed to Audit and Risk Management Committee, Effective September 28, 2024

Shareholders May Be More Conservative With LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation For Now

Take Care Before Diving Into The Deep End On LYC Healthcare Berhad (KLSE:LYC)

Full year 2024 earnings released: RM0.029 loss per share (vs RM0.035 loss in FY 2023)

LYC Healthcare Berhad, Annual General Meeting, Sep 27, 2024

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2024 earnings released: RM0.03 loss per share (vs RM0.035 loss in FY 2023)

New minor risk - Share price stability

LYC Healthcare Berhad (KLSE:LYC) Doing What It Can To Lift Shares

Lyc Healthcare Berhad Appoints Chong Sook Peng as Chief Financial Officer

Third quarter 2024 earnings released: RM0.006 loss per share (vs RM0.007 loss in 3Q 2023)

LYC Healthcare Berhad Announces Resignation of Mr. Cheah SEK Hon as Chief Financial Officer , Effective from 28 April 2024

LYC Healthcare Berhad Announces Resignation of Encik Ahmad Rafique Bin Mat Tahir as Chief Operating Officer, Effective 19 February.2024

Second quarter 2024 earnings released: RM0.006 loss per share (vs RM0.009 loss in 2Q 2023)

LYC Healthcare Berhad has filed a Follow-on Equity Offering in the amount of MYR 12.804571 million.

New minor risk - Share price stability

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad, Annual General Meeting, Sep 21, 2023

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad Appoints Poh Zuan Yin as Independent and Non Executive Member of Audit Committee

LYC Healthcare Berhad (KLSE:LYC) acquired 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei.

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Third quarter 2023 earnings released: RM0.007 loss per share (vs RM0.007 loss in 3Q 2022)

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Second quarter 2023 earnings released: RM0.009 loss per share (vs RM0.007 loss in 2Q 2022)

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

LYC Healthcare Berhad announced a financing transaction

Full year 2022 earnings released: RM0.021 loss per share (vs RM0.033 loss in FY 2021)

LYC Healthcare Berhad, Annual General Meeting, Sep 22, 2022

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad Announces Appointment of Mr. Cheah SEK Hon as Chief Financial Officer

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

LYC Healthcare Berhad (KLSE:LYC) agreed to acquire Tao Global Ventures Sdn Bhd from Dinesh A/L Kanasen and Sarahanna A/P Selvarajah for RMB 4 million.

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings released: RM0.033 loss per share (vs RM0.029 loss in FY 2020)

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2021 earnings released: RM0.032 loss per share (vs RM0.029 loss in FY 2020)

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Third quarter 2021 earnings released: RM0.013 loss per share (vs RM0.006 loss in 3Q 2020)

Non-Independent Non-Executive Director has left the company

LYC Healthcare Berhad Announces Resignation of Josephie Sui Sze Pin as Non Independent and Non Executive Member of Remuneration Committee

New 90-day low: RM0.25

New 90-day low: RM0.29

New 90-day low: RM0.30

New 90-day low: RM0.32

Second quarter 2021 earnings released: RM0.008 loss per share

LYC Healthcare Berhad (KLSE:LYC) acquired remaining 49% stake in LYC Cosmetic & Aesthetic Sdn Bhd from Xing Dao International Pte. Ltd for MYR 0.05 million.

New 90-day low: RM0.33

First quarter earnings released

First quarter earnings released

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven